Cagent Vascular
PrivateLast Round
Series D
May 19, 2026
Total Funding Raised
$98.92M
Company Overview
Cagent Vascular is a medical device company specializing in next-generation intravascular technology for the treatment of diseased peripheral arteries through a minimally invasive vessel dilatation device that enhances arterial expansion and improves patient outcomes.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cagent Vascular Comps
Public and private peers based on sector, stage, and business model.
Cagent Vascular Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | May 19, 2026 | ||||
| VC Round | Feb 20, 2025 | ||||
| Series C | Feb 20, 2024 | ||||
| Series B Extension | Jun 17, 2021 | ||||
| Series B | Jul 12, 2018 | ||||
Series A | Feb 28, 2017 |
Key People
Founding team and executive leadership
Cagent Vascular Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tech-Synergy | Series B |
| U.S. Venture Partners | Series D, Series C |
| Synergy Ventures | Series B |
| Ben Franklin Technology Partners of Southeastern Pennsylvania | Series A |
| Astoria Health Investors | Series D |
| Trinity Capital | VC Round |
| Sectoral | Series C, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
$41M round led by Astoria Health Investors and U.S. Venture Partners
- Apr 3, 2025
Partnered with 3comma Medical GmbH.
Cagent Vascular Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cagent Vascular's valuation, stock price, and market status.
